India's Forward Momentum in Pharmaceuticals

A major producer and exporter of formulated, low-cost generic pharmaceuticals, India increased its exports to major markets during 2011–17, including sub-Saharan Africa (SSA) and the United States. India is also taking steps to produce more innovative pharmaceuticals through such measures as accessing U.S. technology through mergers, acquisitions, and licensing, and by also adding and expanding production and other facilities in the United States

MoreLess

Year of publication:	2018
Authors:	Nesbitt, Elizabeth
Publisher:	[2018]: [S.l.] : SSRN
Subject:	Indien \| India \| Pharmaindustrie \| Pharmaceutical industry \| Arzneimittel \| Pharmaceuticals \| Kapitaleinkommen \| Capital income \| Arzneimittelmarkt \| Pharmaceutical market \| Derivat \| Derivative

freely available

Full text |

More access options

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (2 p)
Type of publication:	Book / Working Paper
Language:	English
Notes:	In: U.S. International Trade Commission (USITC), Executive Briefings on Trade, May 2018 Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments May 2018 erstellt
Classification:	F13 - Commercial Policy; Protection; Promotion; Trade Negotiations ; O1 - Economic Development
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10012915860